BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 26874697)

  • 1. Skp2 Regulates the Expression of MMP-2 and MMP-9, and Enhances the Invasion Potential of Oral Squamous Cell Carcinoma.
    Yamada S; Yanamoto S; Naruse T; Matsushita Y; Takahashi H; Umeda M; Nemoto TK; Kurita H
    Pathol Oncol Res; 2016 Jul; 22(3):625-32. PubMed ID: 26874697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skp2 is oncogenic and overexpressed in human cancers.
    Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
    Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH
    Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion.
    Pramanik KK; Nagini S; Singh AK; Mishra P; Kashyap T; Nath N; Alam M; Rana A; Mishra R
    Cell Oncol (Dordr); 2018 Feb; 41(1):47-60. PubMed ID: 29134466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells.
    Hung WC; Tseng WL; Shiea J; Chang HC
    Cancer Lett; 2010 Feb; 288(2):156-61. PubMed ID: 19625121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation.
    Kitajima S; Kudo Y; Ogawa I; Bashir T; Kitagawa M; Miyauchi M; Pagano M; Takata T
    Am J Pathol; 2004 Dec; 165(6):2147-55. PubMed ID: 15579456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERK-mediated upregulation of matrix metalloproteinase-2 promotes the invasiveness in human oral squamous cell carcinoma (OSCC).
    Pramanik KK; Mishra R
    Exp Cell Res; 2022 Feb; 411(1):112984. PubMed ID: 34951997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.
    Kudo Y; Kitajima S; Sato S; Miyauchi M; Ogawa I; Takata T
    Cancer Res; 2001 Oct; 61(19):7044-7. PubMed ID: 11585732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma.
    Chiang WF; Hwang TZ; Hour TC; Wang LH; Chiu CC; Chen HR; Wu YJ; Wang CC; Wang LF; Chien CY; Chen JH; Hsu CT; Chen JY
    Oral Oncol; 2013 Jun; 49(6):534-41. PubMed ID: 23375593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma.
    Quan J; Zhou C; Johnson NW; Francis G; Dahlstrom JE; Gao J
    Pathology; 2012 Apr; 44(3):221-7. PubMed ID: 22406484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BubR1 Acts as a Promoter in Cellular Motility of Human Oral Squamous Cancer Cells through Regulating MMP-2 and MMP-9.
    Chou CK; Wu CY; Chen JY; Ng MC; Wang HM; Chen JH; Yuan SS; Tsai EM; Chang JG; Chiu CC
    Int J Mol Sci; 2015 Jul; 16(7):15104-17. PubMed ID: 26151845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation.
    Kudo Y; Kitajima S; Ogawa I; Kitagawa M; Miyauchi M; Takata T
    Mol Cancer Ther; 2005 Mar; 4(3):471-6. PubMed ID: 15767556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.
    Masuda TA; Inoue H; Sonoda H; Mine S; Yoshikawa Y; Nakayama K; Nakayama K; Mori M
    Cancer Res; 2002 Jul; 62(13):3819-25. PubMed ID: 12097295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muc-1 promotes migration and invasion of oral squamous cell carcinoma cells via PI3K-Akt signaling.
    Li P; Xiao LY; Tan H
    Int J Clin Exp Pathol; 2015; 8(9):10365-74. PubMed ID: 26617744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
    Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
    Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells.
    Zhang E; Liu S; Xu Z; Huang S; Tan X; Sun C; Lu L
    Tumour Biol; 2014 Sep; 35(9):8801-11. PubMed ID: 24879625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-378-3p/5p suppresses the migration and invasiveness of oral squamous carcinoma cells by inhibiting KLK4 expression.
    Cui Z; Sun S; Liu Q; Zhou X; Gao S; Peng P; Li Q
    Biochem Cell Biol; 2020 Apr; 98(2):154-163. PubMed ID: 31265790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
    Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
    Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of SOX7 induces cell proliferation and invasion and correlates with poor prognosis in oral squamous cell carcinoma.
    Oh KY; Hong KO; Huh YS; Lee JI; Hong SD
    J Oral Pathol Med; 2017 Oct; 46(9):752-758. PubMed ID: 28266739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity.
    Kato K; Hara A; Kuno T; Kitaori N; Huilan Z; Mori H; Toida M; Shibata T
    J Cancer Res Clin Oncol; 2005 Jun; 131(6):340-6. PubMed ID: 15614523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.